Some fused heterocyclic compounds as eukaryotic topoisomerase II inhibitors
- 30 April 2004
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 317 (2), 670-674
- https://doi.org/10.1016/j.bbrc.2004.03.093
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Some new bi- and ter-benzimidazole derivatives as topoisomerase I inhibitorsIl Farmaco, 2003
- Synthesis and microbiological activity of some novel 5-benzamido- and 5-phenylacetamido- substituted 2-phenylbenzoxazole derivativesIl Farmaco, 2000
- Synthesis and antimicrobial activity of some novel 2,5- and/or 6-substituted benzoxazole and benzimidazole derivativesEuropean Journal of Pharmaceutical Sciences, 1999
- Synthesis and microbiological activity of some novel 5- or 6-methyl-2-(2,4-disubstituted phenyl) benzoxazole derivativesIl Farmaco, 1998
- Synthesis and Evaluation of Terbenzimidazoles as Topoisomerase I InhibitorsJournal of Medicinal Chemistry, 1995
- Structure-activity relationships of some antimicrobial 5-substituted 2-(3-pyridyl) benzoxazoles using quantum-chemical calculationsInternational Journal of Pharmaceutics, 1994
- The synthesis and the structure-activity relationships of some substituted benzoxazoles, oxazolo(4,5-b)pyridines, benzothiazoles and benzimidazoles as antimicrobial agentsEuropean Journal of Medicinal Chemistry, 1992
- Potentiation by phenylbisbenzimidazoles of cytotoxicity of anticancer drugs directed against topoisomerase IIEuropean Journal of Cancer and Clinical Oncology, 1990
- In vitro assays used to measure the activity of topoisomerasesAntimicrobial Agents and Chemotherapy, 1990
- DNA TOPOISOMERASESAnnual Review of Biochemistry, 1985